VP
Verrica Pharmaceuticals Inc.
SEC filingPharmaceuticals · West Chester, PA
Amount raised$50Msold at filing
Total offering$50M
Investors in the raise21count reported to the SEC
FiledDec 10, 2025first sale Nov 25, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Mark B. PrygockiDirector
Noah RosenbergExecutive Officer
Diem B. NguyenDirector
John KirbyExecutive Officer
Gavin B. CorcoranDirector
Jayson RiegerExecutive Officer, Director
Paul B. ManningDirector
David ZawitzExecutive Officer
Lawrence B. EichenfieldDirector
Sean B. StalfortDirector
Executive officers, directors and promoters as listed on the Form D.